top of page
Writer's pictureCaretology

FDA approves new Parkinson’s treatment based on clinical trial led by USF Health faculty


The U.S. Food and Drug Administration (FDA) approved on Aug. 7 a new medication that lasts longer and requires fewer doses for treating Parkinson’s Disease, potentially offering patients significant relief from the disease’s debilitating symptoms.


The new formulation is an oral formulation of carbidopa/levodopa (CD/LD) that combines both immediate-release (IR) granules and extended-release (ER) pellets.

5 views0 comments

Recent Posts

See All

The 10-10-10 Rule

The 10-10-10 Rule encourages leaders to evaluate the consequences of your decisions over three distinct time frames:

Comentarios


bottom of page